<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01444664</url>
  </required_header>
  <id_info>
    <org_study_id>20137</org_study_id>
    <nct_id>NCT01444664</nct_id>
  </id_info>
  <brief_title>Aneurysm Wall Histology Registry</brief_title>
  <official_title>Aneurysm Wall Histology and Correlation With Cerebrospinal Fluid and Blood Plasma Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal University Hospital Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Providence Health &amp; Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Methodist Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective registry is to determine if patients harboring intracranial
      aneurysms have any predictive markers between aneurysm wall tissue, cerebrospinal fluid and
      blood plasma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To design a registry to evaluate the wall of intracranial aneurysms during open surgical
      clipping by direct photographic appearance, wall biopsy samples, CSF and blood plasma fluid
      collection (Interleukins; IL-8/ Matrix Metalloproteinase; MMP-9) for complete evaluation and
      comparison.

      The focus of the registry will be to determine the presence of aneurysmal wall defects, mural
      clot, atherosclerotic and atheroma, wall permeability and delamination. These findings will
      then be correlated to the collected CSF and blood values to determine if there is any direct
      features of the aneurysm wall that would predict any of the reported post embolic syndromes.
      The collected data can also be correlated to the peroperative imaging, (MRI, CT and
      Angiogram).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Histological Change</measure>
    <time_frame>an average of 1 day after aneurysm treatment an analysis of the histological sample, CSF sample, and plasma samples will occur</time_frame>
    <description>To determine the relative and absolute differences in histological changes as seen in the tissue samples comparing this to the CSF and blood plasma samples. To also determine if there is any gene expressions that can be utilized as predictive markers in this cohort of patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment related morbidity and mortality</measure>
    <time_frame>up to approximately 1 year post treatment</time_frame>
    <description>Secondary analyses will be performed to compare treatment related morbidity and mortality,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcome</measure>
    <time_frame>approximately clinical outcome at 6 months after surgical clipping at routine follow up visit and approximately 12 months after clipping at routine follow up visit if indicated</time_frame>
    <description>clinical outcome at approximately 6 months after surgical clipping at routine follow up visit and approximately 12 months after clipping at routine follow up visit if indicated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding Rate</measure>
    <time_frame>post treatment during approximate follow up periods 6mo and 12mo clinical follow up</time_frame>
    <description>bleeding rate post treatment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Brain Aneurysm</condition>
  <arm_group>
    <arm_group_label>Aneurysm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical Clipping of Aneurysm</intervention_name>
    <description>Surgical clipping of intracranial aneurysm</description>
    <arm_group_label>Aneurysm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient &gt; 18 years but &lt; 80 years of age

          -  Patient with an unruptured Intracranial aneurysm 8mm or larger

          -  Patient that surgical exposure and clipping will be the primary treatment option

        Exclusion Criteria:

          -  Any patient that has a ruptured intracranial aneurysm

          -  Any Pediatric patients

          -  Any patient presenting with any pre-treatment intracranial lesions

               -  Vascular malformations

               -  Hemorrhage

               -  Normal Pressure Hydrocephalus

               -  Obstructive Hydrocephalus

               -  White matter disease

               -  Tumors

               -  Trauma

               -  Other vascular type lesions

          -  Any meningitis type symptoms

          -  Medical or surgical co-morbidities such that the patient's life expectancy is less
             than 1 year

          -  Inability to obtain consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry Woo</last_name>
    <role>Principal Investigator</role>
    <affiliation>SUNY - Stonybrook</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arthur Adam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mike Kelly</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal University Hospital Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Illinois</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Goodman Campbell</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208-3412</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY - Stonybrook University Medical Center</name>
      <address>
        <city>Stonybrook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Health</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Healthcare - Memphis</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Ontario</state>
        <zip>S7N OW8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Weir B. Unruptured intracranial aneurysms: a review. J Neurosurg. 2002 Jan;96(1):3-42. Review.</citation>
    <PMID>11794601</PMID>
  </reference>
  <reference>
    <citation>Ronkainen A, Hernesniemi J. Subarachnoid haemorrhage of unknown aetiology. Acta Neurochir (Wien). 1992;119(1-4):29-34.</citation>
    <PMID>1481749</PMID>
  </reference>
  <reference>
    <citation>STEHBENS WE. ANEURYSMS AND ANATOMICAL VARIATION OF CEREBRAL ARTERIES. Arch Pathol. 1963 Jan;75:45-64.</citation>
    <PMID>14087271</PMID>
  </reference>
  <reference>
    <citation>Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006 Aug 31;355(9):928-39. Review.</citation>
    <PMID>16943405</PMID>
  </reference>
  <reference>
    <citation>Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993 May;24(5):639-46.</citation>
    <PMID>8488517</PMID>
  </reference>
  <reference>
    <citation>Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke. 2003 Aug;34(8):1852-7. Epub 2003 Jun 26.</citation>
    <PMID>12829865</PMID>
  </reference>
  <reference>
    <citation>Sahs AL. Observations on the pathology of saccular aneurysms. J Neurosurg. 1966 Apr;24(4):792-806.</citation>
    <PMID>5934137</PMID>
  </reference>
  <reference>
    <citation>Scanarini M, Mingrino S, Giordano R, Baroni A. Histological and ultrastructural study of intracranial saccular aneurysmal wall. Acta Neurochir (Wien). 1978;43(3-4):171-82.</citation>
    <PMID>707175</PMID>
  </reference>
  <reference>
    <citation>Krex D, Schackert HK, Schackert G. Genesis of cerebral aneurysms--an update. Acta Neurochir (Wien). 2001;143(5):429-48; discussion 448-9. Review.</citation>
    <PMID>11482693</PMID>
  </reference>
  <reference>
    <citation>Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999 Jul;30(7):1396-401.</citation>
    <PMID>10390313</PMID>
  </reference>
  <reference>
    <citation>Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999 Nov;45(5):1137-46; discussion 1146-7.</citation>
    <PMID>10549930</PMID>
  </reference>
  <reference>
    <citation>Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998 Sep;89(3):431-40.</citation>
    <PMID>9724118</PMID>
  </reference>
  <reference>
    <citation>Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K. Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol. 2000 Nov;100(5):475-80.</citation>
    <PMID>11045669</PMID>
  </reference>
  <reference>
    <citation>Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol. 1994 Jul;53(4):399-406.</citation>
    <PMID>8021714</PMID>
  </reference>
  <reference>
    <citation>Aydin F. Do human intracranial arteries lack vasa vasorum? A comparative immunohistochemical study of intracranial and systemic arteries. Acta Neuropathol. 1998 Jul;96(1):22-8.</citation>
    <PMID>9678510</PMID>
  </reference>
  <reference>
    <citation>Ushikoshi S, Kikuchi Y, Houkin K, Miyasaka K, Abe H. Aggravation of brainstem symptoms caused by a large superior cerebellar artery aneurysm after embolization by Guglielmi detachable coils--case report. Neurol Med Chir (Tokyo). 1999 Jul;39(7):524-9.</citation>
    <PMID>10437381</PMID>
  </reference>
  <reference>
    <citation>Meyers PM, Lavine SD, Fitzsimmons BF, Commichau C, Parra A, Mayer SA, Solomon RA, Connolly ES Jr. Chemical meningitis after cerebral aneurysm treatment using two second-generation aneurysm coils: report of two cases. Neurosurgery. 2004 Nov;55(5):1222.</citation>
    <PMID>15791738</PMID>
  </reference>
  <reference>
    <citation>Berenstein A, Song JK, Niimi Y, Namba K, Heran NS, Brisman JL, Nahoum MC, Madrid M, Langer DJ, Kupersmith MJ. Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experience. AJNR Am J Neuroradiol. 2006 Oct;27(9):1834-40.</citation>
    <PMID>17032853</PMID>
  </reference>
  <reference>
    <citation>Bendszus M, Solymosi L. Cerecyte coils in the treatment of intracranial aneurysms: a preliminary clinical study. AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2053-7.</citation>
    <PMID>17110665</PMID>
  </reference>
  <reference>
    <citation>Deshaies EM, Adamo MA, Boulos AS. A prospective single-center analysis of the safety and efficacy of the hydrocoil embolization system for the treatment of intracranial aneurysms. J Neurosurg. 2007 Feb;106(2):226-33.</citation>
    <PMID>17410704</PMID>
  </reference>
  <reference>
    <citation>Im SH, Han MH, Kwon BJ, Jung C, Kim JE, Han DH. Aseptic meningitis after embolization of cerebral aneurysms using hydrogel-coated coils: report of three cases. AJNR Am J Neuroradiol. 2007 Mar;28(3):511-2.</citation>
    <PMID>17353325</PMID>
  </reference>
  <reference>
    <citation>Stracke CP, Krings T, Möller-Hartmann W, Mahdavi A, Klug N. Severe inflammatory reaction of the optic system after endovascular treatment of a supraophthalmic aneurysm with bioactive coils. AJNR Am J Neuroradiol. 2007 Aug;28(7):1401-2.</citation>
    <PMID>17698551</PMID>
  </reference>
  <reference>
    <citation>Schmidt GW, Oster SF, Golnik KC, Tumialán LM, Biousse V, Turbin R, Prestigiacomo CJ, Miller NR. Isolated progressive visual loss after coiling of paraclinoid aneurysms. AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1882-9.</citation>
    <PMID>17998416</PMID>
  </reference>
  <reference>
    <citation>Kang HS, Han MH, Lee TH, Shin YS, Roh HG, Kwon OK, Kwon BJ, Kim SY, Kim SH, Byun HS. Embolization of intracranial aneurysms with hydrogel-coated coils: result of a Korean multicenter trial. Neurosurgery. 2007 Jul;61(1):51-8; discussion 58-9.</citation>
    <PMID>17621018</PMID>
  </reference>
  <reference>
    <citation>Pickett GE, Laitt RD, Herwadkar A, Hughes DG. Visual pathway compromise after hydrocoil treatment of large ophthalmic aneurysms. Neurosurgery. 2007 Oct;61(4):E873-4; discussion E874.</citation>
    <PMID>17986922</PMID>
  </reference>
  <reference>
    <citation>Horie N, Kitagawa N, Morikawa M, Tsutsumi K, Kaminogo M, Nagata I. Progressive perianeurysmal edema induced after endovascular coil embolization. Report of three cases and review of the literature. J Neurosurg. 2007 May;106(5):916-20. Review.</citation>
    <PMID>17542541</PMID>
  </reference>
  <reference>
    <citation>Marchan EM, Sekula RF Jr, Ku A, Williams R, O'Neill BR, Wilberger JE, Quigley MR. Hydrogel coil-related delayed hydrocephalus in patients with unruptured aneurysms. J Neurosurg. 2008 Aug;109(2):186-90. doi: 10.3171/JNS/2008/109/8/0186.</citation>
    <PMID>18671628</PMID>
  </reference>
  <reference>
    <citation>Fanning NF, Willinsky RA, ter Brugge KG. Wall enhancement, edema, and hydrocephalus after endovascular coil occlusion of intradural cerebral aneurysms. J Neurosurg. 2008 Jun;108(6):1074-86. doi: 10.3171/JNS/2008/108/6/1074.</citation>
    <PMID>18518706</PMID>
  </reference>
  <reference>
    <citation>White JB, Cloft HJ, Kallmes DF. But did you use HydroCoil? Perianeurysmal edema and hydrocephalus with bare platinum coils. AJNR Am J Neuroradiol. 2008 Feb;29(2):299-300. Epub 2007 Nov 16.</citation>
    <PMID>18024573</PMID>
  </reference>
  <reference>
    <citation>Marden FA, Putman CM. Perianeurysm edema with second-generation bioactive coils. Surg Neurol. 2008 Jun;69(6):627-32; discussion 632. Epub 2007 Oct 31.</citation>
    <PMID>17976696</PMID>
  </reference>
  <reference>
    <citation>Turner RD, Byrne JV, Kelly ME, Mitsos AP, Gonugunta V, Lalloo S, Rasmussen PA, Fiorella D. Delayed visual deficits and monocular blindness after endovascular treatment of large and giant paraophthalmic aneurysms. Neurosurgery. 2008 Sep;63(3):469-74; discussion 474-5. doi: 10.1227/01.NEU.0000324730.37144.4B.</citation>
    <PMID>18812958</PMID>
  </reference>
  <reference>
    <citation>Im SH, Han MH, Kwon OK, Kwon BJ, Kim SH, Kim JE, Oh CW. Endovascular coil embolization of 435 small asymptomatic unruptured intracranial aneurysms: procedural morbidity and patient outcome. AJNR Am J Neuroradiol. 2009 Jan;30(1):79-84. doi: 10.3174/ajnr.A1290. Epub 2008 Sep 3.</citation>
    <PMID>18768715</PMID>
  </reference>
  <reference>
    <citation>Killer M, Baltsavias G, Huemer M, Richling B. Visual worsening after incomplete coiling of a small asymptomatic aneurysm: case report and review of the literature. Minim Invasive Neurosurg. 2009 Feb;52(1):39-43. doi: 10.1055/s-0028-1104565. Epub 2009 Feb 26. Review.</citation>
    <PMID>19247904</PMID>
  </reference>
  <reference>
    <citation>Nishino K, Ito Y, Hasegawa H, Shimbo J, Kikuchi B, Fujii Y. Development of cranial nerve palsy shortly after endosaccular embolization for asymptomatic cerebral aneurysm: report of two cases and literature review. Acta Neurochir (Wien). 2009 Apr;151(4):379-83. doi: 10.1007/s00701-009-0234-4. Epub 2009 Mar 5.</citation>
    <PMID>19262981</PMID>
  </reference>
  <reference>
    <citation>Hara A, Yoshimi N, Mori H. Evidence for apoptosis in human intracranial aneurysms. Neurol Res. 1998 Mar;20(2):127-30.</citation>
    <PMID>9522347</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2011</study_first_submitted>
  <study_first_submitted_qc>September 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2011</study_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

